Zevalin and Velcade in Relapsed/Refractory Mantle Cell Lymphoma
Clinical trial NCT01497275 · TERMINATED
Trial details
- NCT number
- NCT01497275
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-05-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.